SCHEMBL16210700

SCHEMBL16210700

O=c1cnc2ccccc2n1Cc1ccccc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.72
KMT2A Q03164 3/20 0.72
ALDH1A1 P00352 9/20 0.65
KDM4E B2RXH2 8/20 0.65
HPGD P15428 1/20 0.65
LMNA P02545 3/20 0.60
TSHR P16473 2/20 0.60
CYP2C9 P11712 2/20 0.60
CYP2C19 P33261 2/20 0.60
CYP1A2 P05177 1/20 0.60
CYP3A4 P08684 1/20 0.60
HBB P68871 1/20 0.60
TDP1 Q9NUW8 1/20 0.59
BRD4 O60885 1/20 0.56
HSD17B10 Q99714 3/20 0.55
NPSR1 Q6W5P4 1/20 0.55
MAPK1 P28482 1/20 0.54
CFTR P13569 1/20 0.54
TNF P01375 2/20 0.53
CYP11B1 P15538 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29414257 1.00 MEN1 (0.72) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL29201531 0.89 MEN1 (0.71) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL29201530 0.89 KMT2A (0.71) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL30050434 0.88 MEN1 (0.73) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL28595389 0.88 MEN1 (0.73) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL29201528 0.88 MEN1 (0.69) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL29201529 0.88 MEN1 (0.69) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL17585774 0.87 CYP11B1 (0.59) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL29489100 0.85 ALDH1A1 (0.63) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL28357168 0.85 ALDH1A1 (0.63) MEN1KMT2AALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111689951-A Synthesis method of 1-benzyl-3-alkyl quinoxaline-2 (1H) -ketone 西北师范大学 2020-09-22 CN claimed
CN-120025287-A Method for catalyzing coupling reaction of quinoxalinone and derivative thereof and electrophile by using lithium silicon amide 苏州大学 2025-05-23 CN disclosed
CN-119663301-A Preparation method and application of C3-cyanoalkyl substituted quinoxalinone 安阳工学院 2025-03-21 CN disclosed
CN-118345387-A Method for synthesizing silicon-based substituted quinoxalinone compound by electrochemical Minisci reaction 江苏食品药品职业技术学院 2024-07-16 CN disclosed
CN-118345388-A Method for preparing pyrazolone substituted quinoxalinone derivative through electrochemical promotion 桂林理工大学 2024-07-16 CN disclosed
CN-114524773-B Synthesis method of aryl quinoxaline compound promoted by mechanical force 浙江工业大学 2024-05-28 CN disclosed
CN-118047727-A Method for preparing quinoxaline-2, 3-diketone compound by virtue of regioselective photocatalytic oxidation 浙江工业大学台州研究院 2024-05-17 CN disclosed
CN-117756849-A Preparation method of alkyl thiophosphate compounds containing quinoxalinone structural units 湖南科技学院 2024-03-26 CN disclosed
CN-113861121-B Novel method for generating 2, 3-dihydroxyquinoxaline and derivatives thereof through direct oxidation 桂林理工大学 2023-11-17 CN disclosed
CN-116789610-A Photocatalytic preparation method of quinoxaline-2, 3-diketone compound 湖南科技学院 2023-09-22 CN disclosed
CN-107235923-B Preparation method of 3-aryl quinoxalinone derivatives 河南工业大学 2020-01-21 CN disclosed
CN-110627734-A Preparation method of 3-alkoxy substituted quinoxalinone derivative 浙江工业大学 2019-12-31 CN disclosed
US-9527834-B2 Substituted 1-benzylquinoxalin-2(1H)-one analogs as positive allosteric modulators of muscarinic acetylcholine receptor M1 VANDERBILT UNIVERSITY (US) 2016-12-27 US disclosed
US-9527834-B2 Substituted 1-benzylquinoxalin-2(1H)-one analogs as positive allosteric modulators of muscarinic acetylcholine receptor M1 VANDERBILT UNIVERSITY (US) 2016-12-27 US disclosed
US-9527834-B2 Substituted 1-benzylquinoxalin-2(1H)-one analogs as positive allosteric modulators of muscarinic acetylcholine receptor M1 VANDERBILT UNIVERSITY (US) 2016-12-27 US disclosed
US-20160075690-A1 SUBSTITUTED 1-BENZYLQUINOXALIN-2(1H) ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR M1 NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-03-17 US disclosed
US-20160075690-A1 SUBSTITUTED 1-BENZYLQUINOXALIN-2(1H) ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR M1 NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2016-03-17 US disclosed
CN-105001169-A Synthetic method for 3-aminoquinoxaline-2(1H)-ketone compound UNIV HUAQIAO 2015-10-28 CN disclosed
WO-2014179226-A1 SUBSTITUTED 1-BENZYLQUINOXALIN-2 (1H)-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR M1 VANDERBILT UNIVERSITY (US) 2014-11-06 WO disclosed
WO-2014179226-A1 SUBSTITUTED 1-BENZYLQUINOXALIN-2 (1H)-ONE ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR M1 VANDERBILT UNIVERSITY (US) 2014-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160075690-A1 SUBSTITUTED 1-BENZYLQUINOXALIN-2(1H) ANALOGS AS POSITIVE ALLOSTERIC MODULATORS OF MUSCARINIC ACETYLCHOLINE RECEPTOR M1 CHRM1, CHRM2, CHRM5 MEN1 1762/4885KMT2A 837/4885ALDH1A1 2705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.